Is use of aprotinin safe with deep hypothermic circulatory arrest in aortic surgery? Investigations on blood coagulation

Circulation

Volumn 94, Issue 9 SUPPL., 1996, Pages

  Okita, Yutaka ^a   Takamoto, Shinichi ^a   Ando, Motomi ^a   Morota, Tetsuro ^a   Yamaki, Fumitaka ^a   Kawashima, Yasunaru ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

aneurysm; aorta; coagulation; fibrinolysis; surgery

Indexed keywords

APROTININ;

ADULT; AGED; ANEURYSM; AORTA SURGERY; ARTICLE; BLOOD CLOTTING; DRUG SAFETY; EXTRACORPOREAL CIRCULATION; FEMALE; FIBRINOLYSIS; HEART ARREST; HEMOSTASIS; HUMAN; HYPOTHERMIA; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME;

AGED; AORTIC ANEURYSM; APROTININ; BLOOD COAGULATION; FEMALE; HEART ARREST, INDUCED; HEMOSTATICS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 0002945106     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Effect of aprotinin in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol). J Thorac Cardiovasc Surg. 1989;97: 364-372.
2. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open heart surgery. Lancet. 1987;2:1289-1291.
3. Cosgrove DM, Herci B, Lyttle BW, Taylor PC, Novoa R, Golding LAR, Stewart RW, McCarthy PM, Loop FD. Aprotinin therapy for re-operative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg. 1992;54:1031-1038.
4. Sundt TM, Kouchoukos NT, Saffitz JE, Murphy SF, Wareing TH, Stahl DJ. Renal dysfunction and intravascular coagulation after use of aprotinin in thoracic aortic operations employing hypothermic cardiopulmonary bypass and circulatory arrest. Ann Thorac Surg. 1993; 55:1418-1424.
5. Westaby S, Forni A, Dunning J, Giannopoulos N, O'Reagan D, Drossos G, Pillai R. Aprotinin and bleeding in profoundly hypothermic perfusion. Eur J Cardiothorac Surg. 1994;8:82-86.
6. Kawasuji M, Ueyama K, Sakakibara N, Tedoriya T, Matsunaga Y, Misaki T, Watanabe Y. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass. Ann Thorac Surg. 1993; 55:1205-1209.
7. Carrel T, Bauer E, Laske A, von Segesser L, Turina M. Low-dose aprotinin also allows reduction of blood loss after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1991;102:801-802.
8. Bidstrup BP, Harrison J, Royston D, Taylor KM, Treasure T. Aprotinin therapy in cardiac operation: a report on use in 41 centers in the United Kingdom. Ann Thorac Surg. 1993;55:941-946.
9. Wang JS, Lin CY, Hung WT, Thisted RA, Karp RB. In vitro effects of aprotinin on activated clotting time measured with different activators. J Thorac Cardiovasc Surg. 1992;104:1135-1140.
10. Wendel HP, Heller W, Gallimore MJ, Bantel H, Muller-Beissenhirtz H, Hoffmeister HE. The prolonged activated clotting time (ACT) with aprotinin depends on the type of activator used for measurement. Blood Coagul Fibrinolysis. 1993;4:41-45.
11. Smith CR, Mongero LB, DeRosa CM, Micheler RE, Oz MC. Safety of aprotinin in profound hypothermia and circulatory arrest. Ann Thorac Surg 1994;58:606-608.
12. Lavee J, Raviv Z, Smolinsky A, Savion N, Varon D, Goor DA, Mohr R. Platelet protection by low-dose aprotinin in cardiopulmonary bypass: electron microscopic study. Ann Thorac Surg. 1993;55:114-119.
13. Ueda Y, Miki S, Kusuhara K, Okita Y, Tahata T, Yamanaka K. Deep hypothermic systemic circulatory arrest and continuous retrograde cerebral perfusion for surgery of aortic arch aneurysm. Eur J Cardiothorac Surg. 1992;6:36-41.
14. Takamoto S, Okita Y, Ando M, Morota T, Handa N, Kawashima Y. Retrograde cerebral circulation for distal aortic arch surgery through a left thoracotomy. J Cardiac Surg. 1994;9:576-583.
15. Lemmer JH Jr, Stanford W, Bonney SL, Chomka EV, Karp RB, Laub GW, Rumberger JA, Schaff HV. Aprotinin for coronary artery bypass grafting: effects on postoperative renal function. Ann Thorac Surg. 1995;59:132-136.
16. Lemmer JH Jr, Stanford W, Bonney SL, Breen JF, Chomka EV, Eldredge WJ, Holt WW, Karp RB, Laub GW, Lipton MJ, Schaff HV, Tatooles CJ, Rumberger JA. Aprotinin for coronary artery bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. J Thorac Cardiovasc Surg. 1994;107:543-553.